Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report

Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report

Here, we discuss the safety and management of adverse events associated with pembrolizumab plus axitinib combination therapy for metastatic renal cell carcinoma in patients on hemodialysis. A 76-year-old man was diagnosed with cT3aN0M0 renal cell carcinoma due to gross hematuria. Stereoscopic radiot...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuki Katsumata, Yoshihide Kawasaki, Kayu Tanaka, Daisuke Nakayama, Hiromichi Katayama, Shuichi Shimada, Yohei Satake, Takuma Sato, Naoki Kawamorita, Shinichi Yamashita, Testuya Sato, Kosuke Shoji, Koji Mitsuzuka, Akihiro Ito
Formato: article
Lenguaje:EN
Publicado: Karger Publishers 2021
Materias:
axitinib
hemodialysis
pembrolizumab
renal cell carcinoma
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/f836686a18da49219a96dc9f58f4a191
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f836686a18da49219a96dc9f58f4a191

Ejemplares similares